191 related articles for article (PubMed ID: 28947965)
1. Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.
Jin K; Pandey NB; Popel AS
Oncotarget; 2017 Sep; 8(36):60210-60222. PubMed ID: 28947965
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
Jin K; Pandey NB; Popel AS
Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
[TBL] [Abstract][Full Text] [Related]
3. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
4. Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.
Malone MK; Smrekar K; Park S; Blakely B; Walter A; Nasta N; Park J; Considine M; Danilova LV; Pandey NB; Fertig EJ; Popel AS; Jin K
Cancer Biol Ther; 2020 Jun; 21(6):560-569. PubMed ID: 32213106
[TBL] [Abstract][Full Text] [Related]
5. CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity.
Kim ES; Nam SM; Song HK; Lee S; Kim K; Lim HK; Lee H; Kang KT; Kwon YJ; Chun YJ; Park SY; Jung J; Moon A
Oncogene; 2021 May; 40(18):3245-3259. PubMed ID: 33833397
[TBL] [Abstract][Full Text] [Related]
6. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
8. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
[TBL] [Abstract][Full Text] [Related]
9. The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.
Ryan D; Paul BT; Koziol J; ElShamy WM
Breast Cancer Res; 2019 Apr; 21(1):53. PubMed ID: 31014367
[TBL] [Abstract][Full Text] [Related]
10. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
12. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model.
Guo Y; Fan Y; Pei X
Cancer Med; 2020 Apr; 9(7):2564-2578. PubMed ID: 32037729
[TBL] [Abstract][Full Text] [Related]
13. Interaction of tumor cells and astrocytes promotes breast cancer brain metastases through TGF-β2/ANGPTL4 axes.
Gong X; Hou Z; Endsley MP; Gronseth EI; Rarick KR; Jorns JM; Yang Q; Du Z; Yan K; Bordas ML; Gershan J; Deepak P; Geethadevi A; Chaluvally-Raghavan P; Fan Y; Harder DR; Ramchandran R; Wang L
NPJ Precis Oncol; 2019; 3():24. PubMed ID: 31602400
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Colony-stimulating Factor Mediates the Recruitment of Macrophages in Triple negative Breast Cancer.
Lu X; Yang R; Zhang L; Xi Y; Zhao J; Wang F; Zhang H; Li Z
Int J Biol Sci; 2019; 15(13):2859-2871. PubMed ID: 31853223
[TBL] [Abstract][Full Text] [Related]
16. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.
Rowan BG; Gimble JM; Sheng M; Anbalagan M; Jones RK; Frazier TP; Asher M; Lacayo EA; Friedlander PL; Kutner R; Chiu ES
PLoS One; 2014; 9(2):e89595. PubMed ID: 24586900
[TBL] [Abstract][Full Text] [Related]
17. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
Cook MT; Liang Y; Besch-Williford C; Hyder SM
Breast Cancer (Dove Med Press); 2017; 9():9-19. PubMed ID: 28096694
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.
Chinchar E; Makey KL; Gibson J; Chen F; Cole SA; Megason GC; Vijayakumar S; Miele L; Gu JW
Vasc Cell; 2014; 6():12. PubMed ID: 24914410
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression.
Lee HH; Jung J; Moon A; Kang H; Cho H
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252615
[TBL] [Abstract][Full Text] [Related]
20. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
Wang X; Osada T; Wang Y; Yu L; Sakakura K; Katayama A; McCarthy JB; Brufsky A; Chivukula M; Khoury T; Hsu DS; Barry WT; Lyerly HK; Clay TM; Ferrone S
J Natl Cancer Inst; 2010 Oct; 102(19):1496-512. PubMed ID: 20852124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
